Reprints
PubMed
CAVEAT LECTOR
ACTION OF POLYPEPTIDE GROWTH FACTORS IN COLON CANCER; DEVELOPMENT OF NEW THERAPEUTIC APPROACHES
Subhas Chakrabarty, Sharon Reynolds, Hong mei Wang and Sriram Rajagopal
Division of Laboratory Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030
Received 9/3/97 Accepted 9/15/97
5. REFERENCES
1. P.G. Johnston & C.J. Allegra: Colorectal cancer biology: clinical implications. Seminars in Oncology 22, 418-432 (1995)
2. E.D. Hay: Extracellular Matrix. J Cell Biol 91, 205s-223s (1981)
3. G.M. Edelman: Cell adhesion molecules. Science (Washington, D.C.) 219, 450-457 (1983)
4. E. Ruoslahti & M.D. Pierschbacher: New perspectives in cell adhesion: RGD and integrins. Science (Washington, D.C.) 238, 491-497 (1987)
5. C.Q. Lin & M.J. Bissel: Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J 7, 737-741 (1993)
6. C.D. Roskelley, P.Y. Desprez & M.J. Bissell: Extracellar matrix-dependent tissue-specific gene expression in mammary epithelial cells required both physical and biochemical signal transduction. Proc Natl Acad Sci 91, 12378-12382 (1994)
7. E.A. Clark & J.S. Brugge: Integrins and signal transduction pathway: the road taken. Science (Washington, D.C.) 268, 233-238 (1995)
8. R.H. Kramer, J. Enenstein, D.M. Ramos, M.P. Vu & Y.F. Cheng: 1991. The role of integrin receptors in tumor cell adhesion to the microvasculature. In: Microcirculation in cancer metastasis. Eds: Buchanan M R, Weis L, CRC Press, Boca Raton (1991)
9. R.L. Juliano: Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis. Biochim Biophys Acta 907, 261-278 (1987)
10. R.L. Juliano: Signal transduction by integrins and its role in the regulation of tumor growth. Cancer Met Rev 13, 25-30 (1994)
11. Cross, M. and Dexter, T.M. Growth factors in development, transformation, and tumorigenesis. Cell 64:271-280, 1991.
11. M. Cross & T.M. Dexter: Growth factors in development, transformation and tumorigenesis. Cell 64, 271-280 (1991)
12. T.M. Browder, C.E. Dunbar & A.W. Nienhuis: Private and public autocrine loops in neoplastic cells. Cancer Cells 1,9-17 (1989)
13. A. Logan: Intracrine regulation at the nucleus - a further mechanism of growth factor activity? J Endocrinol 125, 339-343 (1990)
14. S. Kerbel: Growth factors as mediators of malignant tumor progression. Cancer Metastasis Rev 12, 215-217 (1993)
15. H.L. Moses, E.Y. Yang & J.A. Pietenpol: TGFß stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63, 245-247 (1990).
16. J.A. Barnard, R.M. Lyons & H.L. Moses: The cell biology of transforming growth factor ß. Biochemica Biophysica Acta 1032, 79-87 (1990)
17. S. Chakrabarty, D. Fan & J. Varani: Regulation of differentiation and cellular proliferation in human colon carcinoma cells by transforming growth factor beta 1 and beta 2. Int J Cancer 46, 493-499 (1990)
18. S.P. Wu, L-Z. Sun, L-Z, J.K.V. Willson, L. Humphrey, R. Kerbel & M.G. Brattain: Repression of autocrine transforming growth factor beta1 and beta2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. Cell Growth and Diff 4, 115-123 (1993)
19. L. Sun, S.P. Wu, K. Coleman, K.C. Fields, L.E. Humphrey & M.G. Brattain: Autocrine transforming growth factor-beta1 and beta2 expression is increased by cell crowding and quiescence in colon carcinoma cells. Exp Cell Res 214, 215-224 (1994)
20. S. Wu, D. Theodorescu, R.S. Kerbel, J.K.V. Willson, K.M. Mulder, L.E. Humphrey & M.G. Brattain: TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J Cell Biol 116, 187-196 (1992)
21. M.S. Steiner: Transforming growth factor-beta and prostate cancer. World J Urol 13, 329-336 (1995)
22. S. Markowitz, J. Wang, L. Myeroff, R. Parsons, L-Z Sun, J. Lutterbaugh, R.S. Fan, E. Zborowska, B. Volgelstein, M.G. Brattain & J.K.V. Willson: Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science (Washington, D.C.) 268, 1336-1338 (1995)
23. S. Chakrabarty, A. Tobon, J. Varani & M.G. Brattain: Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta. Cancer Res 48, 4059-4064 (1988)
24. S. Chakrabarty, Y. Jan, M.G. Brattain, A. Tobon & J. Varani: Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-ß. Cancer Res 49, 2112-2117 (1989)
25. S. Chakrabarty, D. Fan & J. Varani: Regulation of
differentiation and cellular proliferation in human colon carcinoma cells by transforming growth factor beta 1 and beta 2. Int J Cancer 46, 493-499 (1990)
26. S. Chakrabarty: Regulation of human colon carcinoma cell adhesion to extracellular matrix by transforming growth factor-beta1. Int J Cancer 50, 968-973 (1992)
27. S. Huang & S. Chakrabarty: Regulation of fibronectin and laminin receptor expression, fibronectin and laminin secretion in human colon cancer cells by transforming growth factor beta1. Int J Cancer 57, 742-746 (1994)
28. S. Huang & S. Chakrabarty: Expression of antisense fibronectin RNA in human colon carcinoma cells disrupts the regulation of carcinoembryonic antigen by transforming growth factor beta1. J Biol Chem 269, 28764-28768 (1994)
29. R.W. Donaldson, S. Nishibe, & G. Carpenter: The structure and physiology of epidermal growth factor and its receptor. In: Advances in Growth Hormone and Growth Factor Research. Eds: Miller E.E, Cocchi D, Locatelli V, Pythagora Press, Roma-Milano, Springer Verlag, Berlin-Heidelberg (1989)
30. M. Shoyab, G.D. Plowman, V.L. McDonald, J.G. Bradley & G.J. Todaro: Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science (Washington D.C.) 243, 1074-1076 (1989)
31. F. Ciardiello, G. Tortora, C. Bianco, M.P. Selvam, F. Basolo, G. Fontanini, F. Pacifico, N. Normanno, R. Brandt, M.G. Perisco, D.S. Salomon & R Bianco: Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides. Oncogene 9, 291-298 (1994)
32. H. Huang, J.M. Trujillo & S. Chakrabarty: Proliferation of human colon cancer cells: role of epidermal growth factor and transforming growth factor . Int J Cancer 52, 978-986 (1992)
33. S. Chakrabarty, S. Rajagopal & S. Huang: Expression of antisense epidermal growth factor receptor RNA downmodulated the malignant behavior of human colon cancer cells. Clin Exp Metastasis 13, 191-195 (1995)
34. S. Rajagopal, S. Huang, T.L. Moskal, B-N. Lee, E.L. El-Naggar, & S.Chakrabarty: Epidermal growth factor expression in human colon and colon carcinomas: Antisense epidermal growth factor receptor RNA downregulates the proliferation of human colon cancer cells. Int J Cancer 62, 661-667 (1995)
35. R. Radinsky, S. Risin, D. Fan, Z. Dong, D. Bielenberg, C.D. Bucana & I.J. Fidler: Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1, 19-31 (1995)
36. S. Chakrabarty, M.G. Brattain, R.L. Ochs & J. Varani: Modulation of fibronectin, laminin and cellular adhesion in the transformation and differentiation of murine AKR fibroblasts. J Cellular Physiol 133, 415-425 (1987)
37. J. Varani & S. Chakrabarty: Modulation of fibronectin synthesis and fibronectin binding during transformation and differentiation of mouse AKR fibroblasts. J Cellular Physiol 143, 445-454 (1990)
38. J. Varani & S. Chakrabarty: Changes in the extracellular matrix during transformation and differentiation. In: Microcirculation in cancer metastasis. Eds: Orr F.W, Buchanan M.R, Weiss L, CRC Press, Boca Raton (1991)
39. D.C. Dean, T,M, Birkenmeier, C.D. Rosen, & S.J. Weintraub: Glycoprotein synthesis and secretion: expression of fibronectin and its cell surface receptors. Am Rev Respir Dis 144, S25-S28 (1991)
40. P.J. Wirth, L.D. Lup, Y. Fujimoto & H.C. Bisgaard: 1992. Two-dimensional electrophoretic analysis of transformation-sensitive polypeptide during chemically, spontaneously, and oncogene-induced transformation of rat liver epithelial cells. Electrophoresis 13, 305-320 (1992)
41. M.A. Schwartz: Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium. J Cell Biol 120, 1003-1010 (1993)
42. H.P. McNamee, D.E. Ingber & M.A. Schwartz: Adhesion to fibronectin stimulates inositol lipid synthesis and enhances PDGF-induced inositol lipid breakdown. J Cell Biol 121, 673-678 (1993)
43. K. Vuori and E. Ruoslahti: Activation of protein kinase C precedes 5ß1 integrin-mediated cell spreading on fibronectin. J Biol Chem 268, 21459-21462 (1993)
44. Z. Zhang, K. Vuori, J.C. Reed and E. Ruoslahti: The 5beta1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci (USA) 92, 6161-6165 (1995)
45. D.G. Tang, M. Tarrien, P. Dobrzynski and K.V. Honn: Melanoma cell spreading on fibronectin induced by 12(S)-HETE involves both protein kinase C-and protein tyrosine kinase-dependent focal adhesion formation and tyrosine phosphorylation of focal adhesion kinase (pp125FAK). J Cell Physiol 165, 291-306 (1995)
46. F.G. Giancotti, and E. Ruoslahti: Elevated levels of the 5beta1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 60, 849-859 (1990)
47. C. Schreiner, M. Fisher, S. Hussein & R.L. Juliano: Increase tumorigenicity of fibronectin recptor deficient Chinese hamster ovary cell variants. Cancer Res 51, 1738-1740 (1991)
48. D.M. Steel & H. Harris: The effect of antisense RNA to fibronectin on the malignancy of hybrids between malanoma and normal fibroblasts. J cell Sci 93, 515-524 (1989)
49. S. Huang, J. Varani & S. Chakrabarty: Control of AKR fibroblast phenotype by fibronectin: regulation of cell-surface fibronectin binding receptor by fibronectin. J Cell Physiol 161, 470-482 (1994)
50. J. Varani, L. Schuger, S.E.G. Fligiel, D.R. Inman & S. Chakrabarty: Production of fibronectin by human tumor cells and interaction with exogenous fibronectin: comparison of cell lines obtained from colon adenocarcinomas and squamous carcinomas of the upper aerodigestive tract. Int J Cancer 47, 421-425 (1991)
51. H. Takei, Y. Iino, J. Horiguchi & T. Yokoe: Immunohistochemical fibronectin staining pattern and prognosis in invasive breast carcinoma. Oncology 52, 106-111 (1995)
52. S. Chakrabarty, S. Rajagopal, N.M. Navone & H.A. Fritsche: Potential of fibronectin as a new tumor marker for prostate cancer. J Clin Ligand Assay 20, 161 (1997)
53. S. Rajagopal, N.M. Navone, P. Troncoso, H.A. Fritsche & S. Chakrabarty: Characterization of the responses of a new human prostate carcinoma cell line MDA PCa2a to epidermal growth factor (EGF), transforming growth factor (TGF) and TGFbeta1. Proc Am Assoc Cancer Res 38, 554 (1997)
54. W.K.L. Chung: The role of stromal-epithelial interaction in normal and malignant growth. Cancer Surveys 23, 33-42 (1995)
55. H. Sonmez, S. Suer, L. Karaaslan, H. Baloglu & E. Kokoglu: Tissue fibronectin levels of human prostate cancer, as a tumor marker. Cancer Biochem Biophys 15, 107-110 (1995)
56. S. Suer, H. Sonmez, I. Karaaslan, H. Baloglu & E. Kokoglu: Tissue sialic acid and fibronectin levels in human prostate cancer. Cancer Letters 99, 135-137 (1996)
57. Clinical applications of TGF beta. Ciba foundation symposium 157. Eds: Bock G.R., Marsh J, John Wiley & Sons, NY (1991).
58. S. Cheifetz, J.A. Weatherbee, M.L-S. Tsang, J.K. Anderson, J.E. Mole, R. Lucas & J Massague: The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell 48, 409-415 (1987)
59. K.A. Piez & M.B. Sporn: Transforming growth factor-ßs chemistry, biology and therapeutics. Annals NY Acad Sciences 593, (1990)
60. J. Massague: Receptors for the TGFbeta family. Cell 69, 1067-1070 (1992)
61. L. Attisano, J. Carcamo, F. Ventura, F.M.B. Weis, J. Massague & J.L. Wrana: Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75, 671-680 (1993)
62. A. Moustakas, H.Y. Lin, Y.I. Henis, J. Plamondon, M.D. O'Connor-McCourt & H.F. Lodish: The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand. J Biol Chem 268, 22215-22218 (1993)
63. R. Ebner, R-H. Chen, L. Shum, S. Lawler, T.F. Zioncheck, A. Lee, A.R. Lopez & R. Derynck: Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. Science (Washington, D.C,) 260, 1344-1348 (1993)
64. R.H. Chen, R. Ebner & R. Derynck: Inactivation of the type II receptor reveals two receptor pathways for the diverse TGFbeta avtivities. Science (Washington, D.C.) 260, 1335-1338 (1993)
65, J.L. Wrana, L. Attisano, R. Wieser, F. Ventura & J. Massague: Mechanism of activation of the TGFbeta receptor. Nature (London) 370, 341-346 (1994)
66. P.H. Howe, C.C. Bascom, M.R. Cunningham & E.B. Leof: Regulation of transforming growth factor beta1 action by multiple transducing pathways: evidence for both G protein-dependent and -independent signaling. Cancer Res 49, 6024-6031 (1989)
67. U.S. Murthy, M.A. Anzano, J.M. Stadel, & R. Greig: Coupling of TGFbeta-induced mitogenesis to G-protein activation in AKR-2B cells. Biochem. Biophys Res Commun 152, 1228-1235 (1988)
68. P.H. Howe & E.B. Leof: Transforming growth factor ß1 treatment of AKR-2B cells is coupled through a pertussis-toxin-sensitive G-protein(s). Biochem J 261, 879-886 (1989)
69. S. Chakrabarty: The role of protein kinase C in transforming growth factor beta1 induction of carcinoembryonic antigen in human colon carcinoma cells. J Cell Physiol 152, 494-499 (1992)
70. S. Chakrabarty & S. Huang: Role of protein kinase C in the induction of carcinoembryonic antigen by transforming growth factorß1. J Cell Physiol 164, 148-153 (1995)
71. Y. Geng & R.A. Weinberg: Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci (USA) 90, 10315-10319 (1993)
72. M.E. Kadin, M.W. Cavaille-Coll, R. Gertz, J. Massague, R. Kataoka, J. Sherlock & S.M. Lanier: Signalling events initiated by transforming growth factor beta1 that require Gi 1. J Biol Chem 268, 19851-19857 (1993)
73. M.G. Brattain, A.E. Levine, S. Chakrabarty, L.C. Yeoman, J.K.V. Willson & B. Long: Heterogeneity of human colon carcinoma. Cancer Met Revs 3, 177-191 (1984)
74. D.F. Pierce Jr., A.E. Gorska, A. Chytil, K.S. Meise, D.L. Page, R.J. Coffey & H.L. Moses: Mammary tumor suppression by transforming growth factor beta1 transgene expression. Proc Natl Acad Sci (USA) 92, 4254-4258 (1995)
75. L. Sun, G. Wu, J.K.V. Willson, E. Zborowska, J. Yang, I. Rajkarunanayake, J. Wang, L.E. Gentry, X-F. Wang & M.G. Brattain: Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast MCF-7 cells. J Biol Chem 42, 26449-26455 (1994)
76. Y. Nishizuka: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science (Washington, D.C.) 258, 607-614 (1992)
77. C.A. O'Brian & N.E. Ward: Biology of the protein kinase C family. Cancer Met Rev 8, 199-214 (1989)
78. P.L. Baron, M.J. Koretz, R.A. Carchman, J.M. Collins, A.S. Tokarz & G.A. Parker: Induction of the expression of differentiation-related antigens on human colon carcinoma cells by stimulating protein kinase C. Arch Surg 125, 344-350 (1990)
79. G.C. Blobe, L.M. Obeid & Y.A. Hannun: Regulation of protein kinase C and role in cancer biology. Cancer Met Rev 13, 411-431 (1994)
80. L. Coussens, P.J. Parker, L. Rhee, T.L. Yang-Feng, E. Chen, M.D. Waterfield, U. Francke & A. Ullrich: Multiple, distinct form of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science (Washington, D.C.) 233, 859-866 (1986)
81. J.L. Knopf, M.H. Lee, L.A. Sultzman, R.W. Kriz, C.R. Loomis, R.M. Hewick & R.M. Bell: Cloning and expression of multiple protein kinase C cDNAs. Cell 46, 491-502 (1986)
82. P. Tremble, R. Chiquet-Ehrismann & Z. Werb: The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol of the Cell 5, 439-453 (1994)
83. D. Wang, T.M. Birkenmeier, J. Yang, S. Venkateswarlu, L. Humphrey, M.G. Brattain & L. Sun: Release from quiescence stimulates the expression of integrin 5beta1 which regulates DNA synthesis in human fibrosarcoma HT1080 cells. J Cell Physiol 164, 499-508 (1995)
84. S. Rajagopal, S. Huang, M. Albitar & S. Chakrabarty: Control of fibronectin receptor expression by fibronectin: antisense fibronectin RNA downmodulates the induction of fibronectin receptor by transforming growth factor beta1. J Cell Physiol 170, 138-144 (1997)
85. S. Reynolds, S. Ragagopal & S. Chakrabarty: Mechanisms of action of differentiation-inducing agents in human colon cancer cells. Proc Am Assoc Cancer Res 38, 498 (1997)
86. Y. Nishizuka: The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature (London) 308, 693-698 (1984)
87. L. Liao, K. Ramsay & S. Jaken: Protein kinase C isozymes in progressively transformed rat embryo fibroblasts. Cell Growth and Diff 5, 1185-1194 (1994)
88. M-H. Disatnik, A.R. Winnier, D. Mochly-Rosen, & C.L. Arteaga: Distinct responses of protein kinase C isozymes to c-erB-2 activation in SKBR-3 human breast carcinoma cells. Cell Growth and Differen 5, 873-880 (1994)
89. B. Liu, R.J. Maher, Y.A. Hannun, A.T. Porter & K.V. Honn: 12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC . J Natl Cancer Inst 86, 1145-1151 (1994)
90. S. Ahmad, J.B. Trepel, S, Ohno, K. Suzuki, T. Tsuruo & R.I. Glazer: Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin. Mol Pharmacol 42,1004-9 (1992)
91. G.C. Blobe, C.W. Sachs, W.A. Khan, D. Fabbro, S. Stabel, W.C. Wetsel, L.M. Obeid, R.L. Fine & Y.A. Hannun: Selective regulation of expression of protein kinase C (PKC) isozymes in multidrug-resistant MCF-7 cells. J Biol Chem 268, 658-64 (1993)
92. H.H. Grunicke & F. Uberall: Protein kinase C modulation. Seminars in Cancer Biol 3, 351-60 (1992)
93. C.A. O'Brian, D. Fan, N.E. Ward, Z. Dong, Z. L. Iwamoto, K.P. Gupta, L.E. Earnest & I.J. Fidler: Transient enhancement of multidrug resistance by the bile acid deoxycholate in murine fibrosarcoma cells in vitro. Biochem Pharmacol 41, 797-806 (1991)
94. K.R. Gravitt, N.E. Ward, D. Fan, J.M. Skibber, B. Levin & C.A. O'Brian: Evidence that protein kinase C activation is a critical event in phorbol ester-induced multiple drug resistance in human colon cancer cells. Biochem Pharm 48, 375-381 (1994)
95. S. Chakrabarty & S. Huang: Modulation of chemosensitivity in human colon carcinoma cells by downregulating protein kinase C expression. J Exp Therapeutics & Oncol 1, 218-221 (1996)
96. M.A. Anzano, D. Rieman, W. Prichett, D.F. Bowen-Pope & R. Greig: Growth factor production by human colon carcinoma cell lines. Cancer Res 49, 2898-2904 (1989)
97. T.A. Libermann, H.R. Nusbaum, N. Razon, R. Kris, I. Lax, H. Soreq, N. Whittle, M.D. Waterfield, A. Ullrich & J. Schlessinger: Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature (London) 313, 144-147 (1985)
98. D.F. Stern, D.L. Hare, M.A. Cecchini & R.A. Weinberg: Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor. Science (Washington, D.C.), 235, 321-324 (1987)
99. F. Ciardiello, N. Kim, T. Saeki, R. Dono, M.G. Persico, G.D. Plowman, J. Garriques, S. Radke, G.J. Todaro & D.S. Salomon: Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci (USA) 88, 7792-7796 (1991)
100. R.J. Coffey, C.M. McCutchen, R. Graves-Deal & W.H. Polk Jr: Transforming growth factors and related peptides in gastrointestinal neoplasia. J Cell Biochem Sppl 16G, 111-118 (1992)
101. K. Khazaie, V. Schirrmacher & R.B. Lichtner: EGF receptor in neoplasia and metastasis. Cancer Metast Rev 12, 155-274 (1993)
102. P. Borlinghaus, S. Wieser & R. Lamerz: Epidermal growth factor, transforming growth factor- , and epidermal growth factor receptor content in normal and carcinomatous gastric and colonic tissue. Clin Invest 71, 903-907 (1993)
103. R.B. Myers, J.E. Kudlow & W.E. Grizzle: Expression of transforming growth factor-alpha, epidermal growth factor and epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia. Modern Pathlogy 6, 733-737 (1993)
104. K.C. Ching, E. Ramsey, N.D. Pettigrew, R. Cunha, M. Jason & J.G. Dodd: Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 126, 151-158 (1993)
105. P. Limonta, R.M. Moretti, D. Dondi, M.M. Marelli & M. Motta: Androgen-dependent prostatic tumors: biosynthesis and possible actions of LHRH. J Steroid Biochem and Mol Biol 49, 347-350 (1994)
106. X.H. Liu, H.S. Wiley & A.W. Meikle: Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor. J Clin Endocrin & Metabol 77, 1472-1478 (1993)
107. C.J. Fong, E.R. Sherwood, J. Mendelsohn, C. Lee & J.M. Kozlowski: Epidermal growth factor receptor monoclonal antibody inhibits constitutive receptor phosphorylation, reduces autonomous growth, and sensitizes androgen-independent prostatic carcinoma cells to tumor necrosis factor alpha. Cancer Res 52, 5887-5892 (1992)
108. R. Lupu, M. Cardillo, L. Harris, M. Hijazi & K. Rosenberg: Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance. Seminars in Cancer Biol 6, 135-145 (1995)
109. L. Zhang, C-J Chang, S.S. Bacus & M-C Hung: Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. Cancer Res 55, 3890-3896 (1995)
110. S.A. Chrysogelos, R.I. Yarden, A.H. Lauber & J.M. Murphy: Mechanisms of EGF receptor regulation in breast cancer cells. Breast Cancer Res & Treatment 31, 227-236 (1994)
111. C.F. LeMaistre, C. Meneghetti, L. Howes & C.K. Osborne: Targeting the EGF receptor in breast cancer treatment. Breast Cancer Res & Treatment 32, 97-103 (1994)
112. L.H. Hartwell, & M.B. Kastan: Cell cycle control and cancer. Science (Washington, D.C.) 266, 1821-1827 (1994)
113. D. Peng, Z. Fan, Y. Lu, T. DeBlasio, H. Scher & J. Mendelsohn: Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostate cancer cell line DU145. Cancer Res 56, 3666-3669 (1996)
114. X. Wu, M. Rubin, Z. Fan, T. DeBlasio, T. Soos, A. Koff & J. Mendelsohn: Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor monoclonal antibody. Oncogene 12, 1397-403 (1996)
115. M.B. Datto, Y. Li, J.F. Panus Y. Xiong & X.F. Wang: Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci (USA) 92, 5545-5549 (1995)
116. C.Y. Li, L. Suardet & J.B. Little: Potential role of WAF1/Cipi/p21 as a mediator of TGF-beta cytoinhibitory effect. J Biol Chem 270, 4971-4974 (1995)
117. A. Richardson, & J.T. Parsons: Signal transduction through integrins: a central role for focal adhesion kinase? BioEssays 17, 229-236 (1995)
118. E. Ruoslahti & J. Reed: Anchorage independence, integrins and apoptosis. Cell 77, 477-478 (1994)
119. M. Schaller & T. Parsons: pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high affinity binding site for Crk. Mol Cell Biol 15, 2635-2645 (1995)
120. S.M. Frisch, K. Vuori, E. Rouslahti & P-Y Chan-Hui: Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134, 793-799 (1996)
121. L.V. Owens, L. Xu, R.J. Craven, G.A. Dent, T.M. Weiner, L. Kornberg, E.T. Liu & W.G. Cance: Overexpression of focal adhesion kinase (p125 FAK) in invasive human tumors. Cancer Res 55, 2752-2755 (1995)
122. L. Xu, L.V. Owens, G.C. Sturge, X. Yang & E.T. Liu: Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth and Differen 7, 413-418 (1996)
123. Antisense RNA and DNA. Current Communications in Molecular Biology Eds: Melton D.A., Cold Spring Harbor Laboratory (1988)
124. F. J-F. Liu: Serum tumor marker assays in cancer patient care. The Cancer Bull U. T. M. D. Anderson Cancer Center 45, 55-63 (1993)
125. J. Thompson & W. Zimmermann: The carcinoembryonic gene family: structure, expression and evolution. Tumor Biol 9, 63-83 (1988)
126. J.A. Thompson: Molecular cloning and expression of carcinoembryonic antigen gene family members. Tumor Biol 16, 10-16 (1995)
127. T. Osaki, Y. Tanio, I. Tachibana, H. Hosoe, T. Kumagai, I. Kawase, S. Oikawa & T. Kishimoto: Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res 54, 5258-5261 (1994)
128. T. Tanaka, F. Kanai, S. Okabe, Y. Yoshida, H. Wakimoto, H. Hamada, Y. Shirotori, K.Lan & M. Ishitobi: Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen producing human gastric carcinoma cells in vitro. Cancer Res 56, 1341-1345 (1996)
129. N. Zhu, D. Liggitt, Y. Liu & R. Debs: Systemic gene expression after DNA delivery into adult mice. Science (Washington, D.C.), 261, 209-211 (1993)
130. D. Yu, A. Matin, W. Xia, F. Sorgi, L. Huang & M.C. Hung: Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress Her-2/neu. Oncogene 11, 1383-1388 (1995)
131. X. Xing, A. Matin, D. Yu, W. Xia, F. Sorgi, L. Huang & M.C. Hung: Mutant SV40 large T antigen as a therapeutic agent for HER-2/neu-overexpressing ovarian cancer. Cancer Gene Therapy 3, 168-174 (1996)